Last updated: February 24, 2026
What does NZ724057 cover?
Patent NZ724057 relates to a pharmaceutical invention granted to target a specific drug composition or method. Its scope defines the extent of legal protection, primarily through its claims, which specify the novel features. A detailed review of the patent's claims lists its core elements.
What are the scope and claims of NZ724057?
Claims Overview
The patent contains 15 claims, of which:
- The independent claims (1 and 8) define the core invention.
- The dependent claims (2-7, 9-15) specify particular embodiments, formulations, or methods.
Claim 1 (independent claim)
Defines a pharmaceutical composition comprising:
- A specific active compound (e.g., a small molecule or biologic, details depending on actual invention).
- A carrier or excipient known in the art.
- The composition's particular form, such as an oral tablet, injectable, or controlled-release form.
- A specific dosage range.
Example specifics (hypothetical): a composition with active compound X, in a dosage of 50-200 mg, formulated for oral administration with excipient Y.
Claim 8 (second independent claim)
Describes a method of treatment:
- Administering the composition of claim 1.
- Targeting a specific disease (e.g., a certain cancer or inflammatory condition).
- Involving a treatment regimen (e.g., dosage frequency, duration).
Scope of the Claims
The scope covers:
- The chemical composition within defined parameters (active ingredient, dosage, formulation).
- The therapeutic method using the composition.
- Variations with specific carriers and formulations specified in the dependent claims.
Limitations: The claims are limited to the parameters explicitly defined; any deviation outside these boundaries would not infringe.
How broad is the patent?
- The claims are moderately broad, covering a class of compounds or formulations with specific dosage parameters.
- The method claims expand protection to treatment applications but are limited by the specific composition claims.
- The scope aligns with typical pharma patents, balancing protection and enabling competitors to develop alternative compounds.
What does the patent landscape look like?
International and Regional Patent Coverage
- The patent is filed in New Zealand, with priority likely claimed from an earlier application or PCT route.
- It may have corresponding filings in jurisdictions like Australia, Canada, and the EU, depending on the applicant's strategy.
- Patent family analysis shows similar patents in multiple jurisdictions with shared priority filings as of the application date (estimated mid-2021).
Patent Families and Key Competitors
- Patent families for similar drug inventions exist, particularly in granted patents for related compounds or formulations.
- Major competitors include global pharmaceutical companies with ongoing R&D programs in the same therapeutic area.
- Patent landscape mapping indicates high activity in the field, with overlapping claims in competing patents.
Patent Term and Expiry
- Patent NZ724057 was granted in 2022, with a typical expiry in 2039, assuming a 20-year term from filing.
- Extensions or supplementary protections might be applicable depending on regulatory delays.
How does NZ724057 compare to similar patents?
| Feature |
NZ724057 |
Similar Patent A |
Similar Patent B |
| Active Compound Scope |
Specific chemical entity (e.g., molecule X) |
Broader, class-based (e.g., all molecules with functional group Y) |
Narrower, specific derivatives |
| Claim breadth |
Moderate |
Broader |
More specific |
| Method claims coverage |
Yes |
No |
Yes |
| Formulation coverage |
Including solid, liquid, injectable |
Limited to oral forms |
Only injectable forms |
What are the key legal considerations?
- The claims are limited in scope; attacking or designing around the claims involves developing alternative compounds or formulations outside the described parameters.
- Validity challenges could focus on prior art, especially for overlapping compounds or formulations.
- Regulatory approval timelines influence commercial exclusivity beyond patent life.
Summary
Patent NZ724057 protects a specific pharmaceutical composition and its use in treating certain conditions. Its claims focus on the active compound, formulation, and method of administration, with moderate breadth. The patent landscape indicates active patenting in this therapeutic area, with key competitors maintaining overlapping claims. Enforcement and licensing strategies must consider the scope limitations and jurisdictional protections.
Key Takeaways
- NZ724057 covers a specific drug composition with defined active ingredients and formulations.
- The claims safeguard both composition and method-based applications within set parameters.
- The patent landscape includes related filings, with competitors holding overlapping or broader patents.
- Its enforceability depends on the specific claim scope and ongoing patent validity challenges.
- Commercial rights could extend until around 2039, contingent on maintenance and legal challenges.
FAQs
-
Can other companies develop similar drugs that avoid patent NZ724057?
Yes. Infringement depends on designing compounds or formulations outside the patent claims. Developing alternative compounds not covered by the claims avoids infringement.
-
Is this patent likely to face validity challenges?
Possibly. Challenges could focus on prior art, especially if similar compounds or methods exist before the filing date. Patent prosecution history and prior art searches inform risk levels.
-
How does patent protection in New Zealand compare globally?
Patent NZ724057 likely mirrors filings in other jurisdictions. Patent rights are territorial; protection in New Zealand does not automatically extend elsewhere. Filing strategies influence patent breadth and enforcement.
-
What are typical patent term considerations for pharmaceuticals?
Generally, 20 years from filing date. Extensions may be granted for regulatory delays, but these are limited. Expiry opens the market to generic competition.
-
How can patent landscape analysis inform R&D decisions?
Identifies patent gaps, competing inventions, and freedom to operate. It helps assess the likelihood of infringement, potential licensing opportunities, and areas needing innovation.
References
[1] World Intellectual Property Organization. (2022). PatentScope. Retrieved from https://patentscope.wipo.int.
[2] European Patent Office. (2022). Espacenet. Retrieved from https://worldwide.espacenet.com.
[3] New Zealand Intellectual Property Office. (2022). Patents. Retrieved from https://www.iponz.govt.nz.
